Cellebrite DI Ltd. (CLBT) Q4 Earnings Meet Estimates

Core Insights - Cellebrite DI Ltd. reported quarterly earnings of $0.10 per share, matching the Zacks Consensus Estimate, but down from $0.11 per share a year ago [1] - The company achieved revenues of $109.05 million for the quarter ended December 2024, exceeding the Zacks Consensus Estimate by 1.11% and up from $93.01 million year-over-year [2] - The stock has gained approximately 13.1% since the beginning of the year, outperforming the S&P 500's gain of 2.9% [3] Earnings Performance - The company has surpassed consensus EPS estimates three out of the last four quarters, with a previous quarter surprise of 27.27% [1] - Current consensus EPS estimate for the upcoming quarter is $0.09, with expected revenues of $107.93 million, and for the current fiscal year, the estimate is $0.44 on revenues of $469.44 million [7] Industry Outlook - The Technology Services industry, to which Cellebrite belongs, is currently ranked in the top 31% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5][6]